HIV treatment produces economic returns through increased work and education, and warrants continued us support

Health Affairs

Volumn 31, Issue 7, 2012, Pages 1470-1477

  Thirumurthy, Harsha ^a   Galárraga, Omar ^b   Larson, Bruce ^c   Rosen, Sydney ^d,e  

^a University of North Carolina at Chapel Hill   (United States)

^b BROWN UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON UNIVERSITY   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; EDUCATION; EMPLOYMENT STATUS; HEALTH CARE COST; HEALTH ECONOMICS; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE; PUBLIC-PRIVATE PARTNERSHIP; UNITED STATES;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CHILD; COST-BENEFIT ANALYSIS; EDUCATION; EMPLOYMENT; HEALTH POLICY; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; SOCIOECONOMIC FACTORS; TERMINAL CARE; UNITED STATES;

EID: 84866281971     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2012.0217     Document Type: Article

References (38)

1. Walker DG, Over M, Bertozzi SM. Can cost studies improve the performance of donor-financed HIV treatment? AIDS. 2011;25(14): 1795-6.
2. Holmes CB, Atun R, Avila C, Blandford JM. Expanding the generation and use of economic and financial data to improve HIV program planning and efficiency: a global perspective. J Acquir Immune Defic Syndr. 2011;57(2 Suppl): S104-8.
3. Bongaarts J, Over M. Public health. Global HIV/AIDS policy in transition. Science. 2010;328(5984): 1359-60.
4. Fox MP, Rosen S, MacLeod WB, Wasunna M, Bii M, Foglia G, et al. The impact of HIV/AIDS on labour productivity in Kenya. Trop Med Int Health. 2004;9(3):318-24.
5. Rosen S, Feeley F, Connelly P, Simon J. The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research. AIDS. 2007; 21(3 Suppl):S41-51.
6. Rosen S, Hamazakaza P, Feeley F, Fox M. The impact of AIDS on government service delivery: the case of the Zambia Wildlife Authority. AIDS. 2007;21(3 Suppl):S53-9.
7. Lamontagne E, Haacker M, Ventelou B, Greener R. Macroeconomic impact of HIV: the need for better modelling. Curr Opin HIV AIDS. 2010;5(3):249-54.
8. Larson BA, Fox MP, Rosen S, Bii M, Sigei C, Shaffer D, et al. Early effects of antiretroviral therapy on work performance: preliminary results from a cohort study of Kenyan agricultural workers. AIDS. 2008;22(3): 421-5.
9. Thirumurthy H, Goldstein M, Zivin JG. The economic impact of AIDS treatment: labor supply in western Kenya. J Hum Resour. 2008;43(3): 511-52.
10. Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, et al. Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment. PLoS One. 2010;5(9):e12731.
11. Thirumurthy H, Jafri A, Srinivas G, Arumugam V, Saravanan RM, Angappan SK, et al. Two-year impacts on employment and income among adults receiving antiretroviral therapy in Tamil Nadu, India: a cohort study. AIDS. 2011;25(2): 239-46.
12. Beard J, Feeley F, Rosen S. Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review. AIDS Care. 2009; 21(11):1343-56.
13. Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, et al. Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One. 2011;6(10):e25310.
14. Larson BA, Fox MP, Rosen S, Bii M, Sigei C, Shaffer D, et al. Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes. BMC Public Health. 2009; 9:240.
15. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lowerincome countries. Bull World Health Organ. 2008;86(7):559-67.
16. Piot P, Greener R, Russell S. Squaring the circle: AIDS, poverty, and human development. PLoS Med. 2007;4(10):e314.
17. Collins DL, Leibbrandt M. The financial impact of HIV/AIDS on poor households in South Africa. AIDS. 2007;21(7 Suppl):S75-S81.
18. Wyss K, Hutton G, N'Diekhor Y. Costs attributable to AIDS at household level in Chad. AIDS Care. 2004; 16(7):808-16.
19. Ngalula J, Urassa M, Mwaluko G, Isingo R, Ties Boerma J. Health service use and household expenditure during terminal illness due to AIDS in rural Tanzania. Trop Med Int Health. 2002;7(10):873-7.
20. Case A, Ardington C. The impact of parental death on school outcomes: longitudinal evidence from South Africa. Demography. 2006;43(3): 401-20.
21. Bennell P. The impact of the AIDS epidemic on the schooling of orphans and other directly affected children in sub-Saharan Africa. J Dev Stud. 2005;41(3):467-88.
22. Gundersen C, Kelly T. School attendance and educational enrollment for maternal orphans in Zimbabwe: an instrumental variables approach. J Afr Dev. 2008;3(1):33-49.
23. Zivin JG, Thirumurthy H, Goldstein M. AIDS treatment and intrahousehold resource allocation: children's nutrition and schooling in Kenya. J Public Econ. 2009;93(7-8):1008-15.
24. D'Adda G, Goldstein M, Zivin JG, Nangami M, Thirumurthy H. ARV treatment and time allocation to household tasks: evidence from Kenya. Afr Dev Rev. 2009;21(1): 180-208.
25. Larson BA. Costs, outcomes, and cost-effectiveness of OVC interventions. Boston (MA): Boston University Center for Global Health and Development; 2010.
26. Matshalaga NR, Powell G. Mass orphanhood in the era of HIV/AIDS. BMJ. 2002;324(7331):185-6.
27. Larson BA. How to evaluate the annual costs of NGO-implemented programs to support orphans and vulnerable children (OVC): a six-step approach. Boston (MA): Boston University Center for Global Health and Development; 2011.
28. Santa-Ana-Tellez Y, Demaria LM, Galárraga O. Costs of interventions for AIDS orphans and vulnerable children. Trop Med Int Health. 2011; 16(11):1417-26.
29. Stover J, Bollinger L, Walker N, Monasch R. Resource needs to support orphans and vulnerable children in sub-Saharan Africa. Health Policy Plan. 2007;22(1):21-7.
30. Van der Borght SF, Janssens V, Schim van der Loeff MF, Kajemba A, Rijckborst H, Lange JM, et al. The Accelerating Access Initiative: experience with a multinational workplace programme in Africa. Bull World Health Organ. 2009;87(10): 794-8.
31. Van der Borght SF, Clevenbergh P, Rijckborst H, Nsalou P, Onyia N, Lange JM, et al. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa. Antivir Ther. 2009;14(1):63-74.
32. Clevenbergh P, Van der Borght SF, van Cranenburgh K, Janssens V, Kitenge Lubangi C, Gahimbaza L, et al. Database-supported teleconferencing: an additional clinical mentoring tool to assist a multinational company HIV/AIDS treatment program in Africa. HIV Clin Trials. 2006;7(5):255-62.
33. Rosen S, Simon J, Vincent JR, MacLeod W, Fox M, Thea DM. AIDS is your business. Harv Bus Rev. 2003;81(2):80-7, 125.
34. Sonnenberg P, Copas A, Glynn JR, Bester A, Nelson G, Shearer S, et al. The effect of HIV infection on time off work in a large cohort of gold miners with known dates of seroconversion. Occup Environ Med. 2011;68(9):647-52.
35. Habyarimana J, Mbakile B, Pop-Eleches C. The impact of HIV/AIDS and ARV treatment on worker absenteeism: implications for African firms. J Hum Resour. 2010;45(4): 809-39.
36. Eholie SP, Nolan M, Gaumon AP, Mambo J, Kouamé-Yebouet Y, Aka-Kakou R, et al. Antiretroviral treatment can be cost-saving for industry and life-saving for workers: a case study from Côte d'Ivoire's private sector. In: Moatti JP, Barnett T, Coriat B, Souteyrand Y, Dumoulin J, Flori YA, editors. Economics of AIDS and access to HIV/AIDS care in developing countries: issues and challenges. Paris: Agence Nationale de Recherches sur le Sida; 2003. p. 329-46.
37. Marseille E, Saba J, Muyingo S, Kahn JG. The costs and benefits of private-sector provision of treatment to HIV-infected employees in Kampala, Uganda. AIDS. 2006;20(6): 907-14.
38. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505.